Form 4: Hyperfine Director Ruth Fattori Receives Stock Options

Director Ruth A. Fattori was granted 157,700 stock options in Hyperfine, Inc. as part of an equity compensation arrangement.

Summary

• Director Ruth A. Fattori acquired 157,700 stock options in Hyperfine, Inc. (HYPR).
• The options have an exercise price of $1.49 per share.
• The grant date for these derivative securities is May 22, 2026.
• The options are set to expire on May 22, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Potential future dilution of existing shareholders upon the exercise of these options.

Risks

• Vesting is contingent upon the director's continued service through the date of the next regular annual stockholders meeting.

Future Outlook

The options vest on the date of the Issuer's next regular annual stockholders meeting, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure board members maintain a vested interest in the company's long-term performance.

Comparison to Industry Standards

• The grant of stock options to directors is consistent with standard compensation practices for mid-cap and small-cap technology and medical device companies.

Stakeholder Impact

• Shareholders may experience minor dilution if these options are exercised in the future.

Next Steps

• Vesting of options at the next regular annual stockholders meeting.

Key Dates

Keywords

Hyperfine, HYPR, Form 4, Insider Trading, Stock Options, Director Compensation